Live Breaking News & Updates on Jamesl Gulley|Page 2

Stay updated with breaking news from Jamesl gulley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Marengo Therapeutics Announces Formation of Scientific Advisory Board to Advance the Company's Development of Novel Therapeutics for Precision Immuno-Oncology

/PRNewswire/ Marengo Therapeutics, Inc., a company pioneering novel immuno-oncology (IO) therapeutics that directly target the Vβ chain of the T cell. ....

United Kingdom , United States , Jamesl Gulley , Lillianl Siu , Andrew Bayliffe , Lillian Siu , James Gulley , Howard Kaufman , E John Wherry , Zhen Su , Richard Schiffrin , Medicine At Emory University , Loma Linda University , National Institute Of Health , National Cancer Institute , University Of Paris Saclay , Tumor Immunotherapy Program , Department Of Systems Pharmacology , Phasei Clinical Trials Program , Perelman School Of Medicine , University Of Toronto , Stanleyn Cohen Biomedical Research Award , Society For Immunotherapy Of Cancer , University Of Pennsylvania Perelman School Medicine , National Institutes Of Health , Thomas Jefferson University ,

JNM Publishes Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

Reston, VA-The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and peer medical groups have issued appropriate use criteria (AUC) for ....

United States , New York , University Of Washington , Ann Arbor , North Carolina , Stanford University , Chapel Hill , Duke University , San Francisco , University Of Virginia , Johns Hopkins University , National Institutes Of Health , University Of Southern California , University Of North Carolina , Loyola University , Jamesl Gulley , Michaelj Morris , Hossein Jadvar , Trevorj Royce , Bridgetf Koontz , Michael Hofman , Danielw Lin , Los Angeles , Felix Feng , Kirstenl Greene , Stefano Fanti ,

Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ Therapies

/PRNewswire/ Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the. ....

Jamesl Gulley , David Sallman , Precigen Ultraporator , Precigen Adenoverse , Helen Sabzevari , Clintt Allen , Maryl Nora Disis , Precigen Ultra , Steven Harasym , Uw Center , Development Agreement , National Cancer Institute , H Lee Moffitt Cancer Center Research Institute , National Institutes Of Health , Clinical Research Division , Drug Administration , University Of Washington Uw Professor Medicine , Exchange Commission , Oncology Service , Department Of Malignant Hematology , Fred Hutchinson Cancer Research Center , Precigen Inc , Translational Medicine , Assistant Member , Malignant Hematology , Moffitt Cancer Center ,

Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts

/PRNewswire/ Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced today. ....

New York , United States , Chadi Nabhan , Jamesl Gulley , Eytan Ruppin , Davidd Halbert , Caris Codeai , Allison Kreutzjans , Cancer Centers , Human Services , National Institutes Of Health , Oncology Service , Cancer Research , Department Of Health , Cari Precision Oncology Alliance , Caris Life Sciences , Cancer Data Science Laboratory , Clinical Center , Caris Precision Oncology Alliance , Caris Life , Medical Oncology Service , Designated Cancer Centers , National Institutes , Whole Exome , Whole Transcriptome Sequencing , Media Contact ,

Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments

/PRNewswire/ Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the. ....

Jamesl Gulley , David Sallman , Maryl Nora Disis , Steven Harasym , Helen Sabzevari , Clintt Allen , Uw Center , H Lee Moffitt Cancer Center Research Institute , National Institutes Of Health , University Of Washington Uw Professor Medicine , Exchange Commission , Oncology Service , Department Of Malignant Hematology , Clinical Research Division At Fred Hutch , Precigen Inc , Translational Medicine , Clinical Research Division , Fred Hutch , Assistant Member , Malignant Hematology , Moffitt Cancer Center , Research Institute , Branch Chief , Medical Oncology Service , National Institutes , Principal Investigator ,